AbbVie 2012 Annual Report Download - page 136

Download and view the complete annual report

Please find page 136 of the 2012 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 200

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200

Name Goal and Expected Result Results Achieved
Richard A. Gonzalez . . A. Adjusted Diluted EPS of $4.99 A. Adjusted Diluted EPS of $5.07
B. Achieve Pharmaceutical B. Achieved—$24,384MM
Products Group Adjusted Sales
of $23,903MM
C. Achieve Pharmaceutical C. Achieved—$8,787MM
Products Group Adjusted
Operating Margin of
$8,214MM
D. Achieve Pharmaceutical D. Achieved—72.3%
Products Group Plan Gross
Margin of 70.8%
Laura J. Schumacher . . A. Adjusted Diluted EPS of $4.99 A. Adjusted Diluted EPS of $5.07
William J. Chase ...... A. Adjusted Diluted EPS of $4.99 A. Adjusted Diluted EPS of $5.07
B. Achieve Pharmaceutical B. Achieved—Margin
Products Group margin contributions worth $66.5 MM
contribution of $50MM identified
C. Achieve Licensing and C. Achieved—$25.4 MM
Acquisition total expense
budget of $28.5MM
Carlos Alban ........ A. Adjusted Diluted EPS of $4.99 A. Adjusted Diluted EPS of $5.07
B. Achieve Proprietary B. Achieved—$18,494MM
Pharmaceuticals Division
Adjusted Sales of $17,752MM
C. Achieve Proprietary C. Achieved—$8,144MM
Pharmaceuticals Division
Adjusted Operating Margin of
$7,535MM
D. Achieve Proprietary D. Achieved—75.7%;
Pharmaceuticals Group Plan Achieved—78.4%
Gross Margin of 74.2% and
2013 Gross Margin
commitment of 77.0%
John M. Leonard ..... A. Adjusted Diluted EPS of $4.99 A. Adjusted Diluted EPS of $5.07
B. Achieve Pharmaceutical B. Achieved—$24,384MM
Products Group Adjusted Sales
of $23,903MM
C. Achieve Pharmaceutical C. Achieved—$8,787MM
Products Group Adjusted
Operating Margin of
$8,214MM
D. Achieve Pharmaceutical D. Achieved—72.3%
Products Group Plan Gross
Margin of 70.8%
22